SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-023291
Filing Date
2022-05-03
Accepted
2022-05-02 19:11:41
Documents
100
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f20f2021_mainzbiomed.htm   iXBRL 20-F 1792937
2 EMPLOYMENT CONTRACT WITH WILLIAM CARAGOL, DATED APRIL 29, 2022 f20f2021ex10-16_mainzbio.htm EX-10.16 104257
3 CERTIFICATION f20f2021ex12-1_mainzbio.htm EX-12.1 11612
4 CERTIFICATION f20f2021ex12-2_mainzbio.htm EX-12.2 11156
5 CERTIFICATION f20f2021ex13-1_mainzbio.htm EX-13.1 5103
11 GRAPHIC img_001.jpg GRAPHIC 7182
12 GRAPHIC img_002.jpg GRAPHIC 41859
  Complete submission text file 0001213900-22-023291.txt   7725372

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE mynz-20211231.xsd EX-101.SCH 112419
7 XBRL CALCULATION FILE mynz-20211231_cal.xml EX-101.CAL 35564
8 XBRL DEFINITION FILE mynz-20211231_def.xml EX-101.DEF 283544
9 XBRL LABEL FILE mynz-20211231_lab.xml EX-101.LAB 575765
10 XBRL PRESENTATION FILE mynz-20211231_pre.xml EX-101.PRE 302348
94 EXTRACTED XBRL INSTANCE DOCUMENT f20f2021_mainzbiomed_htm.xml XML 1216464
Mailing Address ROBERT KOCH STRASSE 50 MAINZ 2M 55129
Business Address ROBERT KOCH STRASSE 50 MAINZ 2M 55129 49 6131 5542860
MAINZ BIOMED N.V. (Filer) CIK: 0001874252 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-41010 | Film No.: 22883858
SIC: 2834 Pharmaceutical Preparations